Healthcare stakeholders are increasingly deploying investments towards technologies such as AR/VR, AI/ML, sensors, platforms, etc., and are focusing on developing relevant digital capabilities to build DTx solutions. By providing access to real-world patient data for improved drug efficacy & individualized therapy, better patient engagement, and reduced cost of care, DTx is uniquely positioned to provide meaningful benefits across the spectrum of healthcare stakeholders.
In this panel discussion, Douglas Lee, Vice President, Business Development & Licensing, Bayer AG Pharmaceuticals, Gerd Hoefner, Senior Vice President Special CTO Projects, Siemens Healthineers, Janet D, Sr. Clinical Director, Medical and Scientific Affairs, Flatiron, Nila Bhakuni, Assistant Vice President, Innovation, Baptist Health South Florida, Shah M Nawaz, Executive Director: Digital, Data Analytics & Technology Engineering, Regeneron Pharmaceuticals, Inc., Suresh kumar R, CTO CCS India & Digital Incubators, GE-Healthcare, Sarika Phatak, Senior Director of Healthcare Products and Solutions, HARMAN, Sidhant Rastogi, Managing Partner, Zinnov discuss about the oppportunities and challenges in digital therapeutics.
-----------------------------------------------------------------------------------------------------------
Subscribe to Zinnov: [ Ссылка ]
-----------------------------------------------------------------------------------------------------------
Get access to Zinnov's Insights and Thought Leadership: [ Ссылка ]
Visit our website to know more: [ Ссылка ].
Or write to us at info@zinnov.com.
-----------------------------------------------------------------------------------------------------------
***Find us on***
Facebook - [ Ссылка ]
Twitter - [ Ссылка ]
LinkedIn - [ Ссылка ]
Instagram - [ Ссылка ]
